[Department of Error] Department of Error
Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018; 391: 1085–96—In this Article (published online first on Jan 24, 2018), J Sullivan should have been listed as a member of the GWPCARE4 Study Group. This correction has been made to the online version as of March 15, 2018, and the printed Article is correct.